Tamoxifen inhibits growth of oestrogen receptor-negative A549 cells

Biochemical Pharmacology

Volumn 47, Issue 2, 1994, Pages 197-202

  Croxtall, J D ^a   Emmas, C ^b   White, J O ^b   Choudhary, Q ^a   Flower, R J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

anti oestrogens; binding protein; fatty acids; ICI 164384 ICI 182780; lung adenocarcinoma

Indexed keywords

4 HYDROXYTAMOXIFEN; ANTIESTROGEN; BINDING PROTEIN; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; OLEIC ACID; STEARIC ACID; TAMOXIFEN;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; NORTHERN BLOTTING; PRIORITY JOURNAL;

CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; HUMAN; OLEIC ACID; OLEIC ACIDS; RECEPTORS, ESTROGEN; STEARIC ACIDS; SUPPORT, NON-U.S. GOV'T; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 0028047133     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(94)90006-X     Document Type: Article

References (33)

1. Effects of oestrogens on cell proliferation and cell cycle kinetics. A hypothesis on the cell cycle effects of antioestrogens
2. Cellular mechanisms in tamoxifen action on tumours
3. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture
4. Model systems for the study of estrogen action in tissue culture
5. High-affinity antioestrogen binding site distinct from the oestrogen receptor
6. An antiestrogen-binding protein in human tissues.
7. Unsaturated fatty acids as endogenous inhibitors of tamoxifen binding to antioestrogen-binding sites
8. Fatty acid modulation of antioestrogen-binding protein in cultured lymphoid cells
9. Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase
10. Evidence that tamoxifen is a histamine antagonist
11. The direct inhibition of prostaglandin synthetase of human breast cancer tissue by tamoxifen
12. Tamoxifen inhibits 5-lipoxygenase in human polymorphonuclear lymphocytes
13. Tamoxifen inhibits lipid peroxidation in cardiac microsomes
14. Triphenylethylenes: a new class of protein kinase C inhibitors
15. Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line
16. N-terminal peptide fragments of lipocortin-1 inhibit A549 cell growth and block EGF-induced stimulation of proliferation
17. Differential regulation of transforming growth factor-βs 1 and 2 by retinoic acid, epidermal growth factor, and dexamethasone in NRK-49F and A549 cel
18. The effect of anti-oestrogens on cell growth and progesterone receptor concentration in human endometrial cancer cells (Ishikawa)
19. Variation of the inhibition of calmodulin dependent cyclic AMP phosphodiesterase amongst analogues of tamoxifen; correlations with cytotoxicity
20. 2+ dependent binding of tamoxifen to calmodulin isolated from bovine brain
21. Protein kinase C subspecies in estrogen receptor-positive and -negative human human breast cancer cell lines
22. Nonsteroidal antioestrogen suppresses protein kinase C-its inhibitory effect on interaction of substrate protein with membrane
23. Differential effects of tamoxifen and analogs with nonbasic side chains on cell proliferation in vitro
24. Antiestrogen-binding sites distinct from the estrogen receptor: subcellular localization, ligand specificity, and distribution in tissues of the rat
25. Physicochemical and genetic evidence for specific antiestrogen binding sites
26. Definition of two distinct mechanisms of action of antiestrogens on human breast cancer cell proliferation using hydroxytriphenylethylenes with high affinity for the estrogen receptor
27. The future of new pure antiestrogens in clinical breast cancer
28. 8th San Antonio Breast Cancer Symposium—Plenary lecture. Autocrine and paracrine growth regulation of human breast cancer
29. Type β transforming growth factor is a growth stimulator and a growth inhibitor
30. TGF-β stimulation of endometrial and breast-cancer cell growth
31. Mechanistic inter-relationships between two superfamilies: the steroid/retinoid receptors and transforming growth factor-β
32. Antioestrogens induce the secretion of active TFG-β from human fetal fibroblasts
33. 1 in human breast cancer in vivo following tamoxifen treatment